Skip to content
Customer service: +33 (0)1 84 17 42 71|pro@carenity.com
LinkedIn
Carenity Pro Logo Carenity Pro Logo Carenity Pro Logo
  • Home
  • About us
    • Our story
    • Our experts
    • Data for Good
    • Contact us
  • Solutions
    • Real-World Evidence Generation
    • Clinical Trial Optimization
    • Scientific communication
    • Patient Live
  • Customers
  • Resources
    • Scientific committee
    • Publications

ms-treatment

ms-treatment

Léa Blaszczynski2018-03-21T18:33:09+01:00March 21st, 2018|

Share this on your social network !

FacebookTwitterLinkedInEmail

Recent posts

  • ENJEUX & PRIORITÉS – Interview de Michael Chekroun, fondateur de Carenity 13 October 2021
  • Impact of Cold Agglutinin Disease and its related Fatigue on Patients’ Daily Life: an Online Survey among 50 US Patients 11 October 2021
  • Impact post déconfinement de la pandémie de COVID 19 sur les patients chroniques en Europe 1 October 2021

GENERAL INFORMATION

  • About us
  • Part of EvidentIQ
  • Work with us
  • Terms and conditions
  • Cookies management

CONTACT INFORMATION

  • pro@carenity.com
  • +33 (0)1 84 17 42 71
CONTACT US

CARENITY PRO: OUR SOLUTIONS

  • Real World Evidence Generation
  • Clinical Trial Optimization
  • Scientific Communication
  • PatientLive
© Copyright 2012 -    |   Carenity   |   All Rights Reserved   |   Carenity is part of the EvidentIQ Group along with Dacima, Fortress Medical Systems and XClinical.
LinkedIn
Page load link
Go to Top